MENGENAI EPISOD INI
MetaOptics Technologies CFO Alex Chu joined Steve Darling from Proactive to discuss the company’s latest milestone as it expands its presence in the United States. The company has officially commenced trading of its American Depositary Shares (ADSs) on the OTCQX market under the ticker symbol MOTLY, while maintaining its primary listing on Singapore’s Catalist exchange under SGX:9MT.
Chu explained that the OTCQX listing is designed to enhance the company’s visibility among North American investors and provide U.S.-based institutions and retail investors with a more convenient avenue to participate in MetaOptics’ growth story. He emphasized that the ADS program is not expected to have any material impact on existing shareholders but is intended to broaden the company’s investor base and improve market accessibility.
The move comes as MetaOptics continues to deepen its engagement with customers, industry partners, and institutional investors in the United States. Following its successful Singapore listing in 2025, the company showcased its technology at CES 2025 and CES 2026 and conducted a series of U.S. roadshows that helped validate its commercialization strategy and growth ambitions.
A key component of that strategy is the establishment of MetaOptics’ first U.S.-based front-end semiconductor fabrication facility. The planned facility will feature advanced 12-inch DUV immersion photolithography equipment and is expected to support the large-scale production of the company’s proprietary metalenses and optical modules.
MetaOptics specializes in glass-based metalens technology enhanced by AI-powered image processing. Its semiconductor optics platform is designed to address growing demand across several high-growth sectors, including co-packaged optics (CPO), mobile devices, augmented and virtual reality, automotive applications, and other emerging technology markets.
Chu said the OTCQX listing represents another step in the company’s international growth strategy, helping align its capital markets presence with its expanding U.S. commercial operations. Management believes greater access to U.S. investors will become increasingly important as the company enters its next phase of technology commercialization, manufacturing scale-up, and global market expansion.
#proactiveinvestors #metaoptics #otcqx MOTLY #SemiconductorTechnology #Metalens #ArtificialIntelligence #OTCQX #ADRListing #Photonics #OpticsInnovation #ARVR #AutomotiveTech #CPO #TechStocks #SmallCapStocks #SteveDarling
Chu explained that the OTCQX listing is designed to enhance the company’s visibility among North American investors and provide U.S.-based institutions and retail investors with a more convenient avenue to participate in MetaOptics’ growth story. He emphasized that the ADS program is not expected to have any material impact on existing shareholders but is intended to broaden the company’s investor base and improve market accessibility.
The move comes as MetaOptics continues to deepen its engagement with customers, industry partners, and institutional investors in the United States. Following its successful Singapore listing in 2025, the company showcased its technology at CES 2025 and CES 2026 and conducted a series of U.S. roadshows that helped validate its commercialization strategy and growth ambitions.
A key component of that strategy is the establishment of MetaOptics’ first U.S.-based front-end semiconductor fabrication facility. The planned facility will feature advanced 12-inch DUV immersion photolithography equipment and is expected to support the large-scale production of the company’s proprietary metalenses and optical modules.
MetaOptics specializes in glass-based metalens technology enhanced by AI-powered image processing. Its semiconductor optics platform is designed to address growing demand across several high-growth sectors, including co-packaged optics (CPO), mobile devices, augmented and virtual reality, automotive applications, and other emerging technology markets.
Chu said the OTCQX listing represents another step in the company’s international growth strategy, helping align its capital markets presence with its expanding U.S. commercial operations. Management believes greater access to U.S. investors will become increasingly important as the company enters its next phase of technology commercialization, manufacturing scale-up, and global market expansion.
#proactiveinvestors #metaoptics #otcqx MOTLY #SemiconductorTechnology #Metalens #ArtificialIntelligence #OTCQX #ADRListing #Photonics #OpticsInnovation #ARVR #AutomotiveTech #CPO #TechStocks #SmallCapStocks #SteveDarling
Bahasa Inggeris
Amerika Syarikat
TRANSKRIP 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CARI EPISOD LEPAS
Cari episod lepas bagi Proactive - Interviews for investors.
EPISOD LAIN DALAM PODCAST INI
Great Plains Metals Corp Executive Director Aidan Bishop joined Steve Darling from to discuss a significant review of historical drilling data from the company’s Goodrich copper-gold project in New South Wales, Australia.
The company reviewed more than 5,000 metres of drilling across 46 histori ...
Connecting Excellence Group Plc (AQSE:XCE, OTCQB:XCELF) CEO Scott Ellam spoke with Proactive's Stephen Gunnion about the company’s first acquisition, James Gray Recruitment, its acquisition pipeline and its Bitcoin treasury strategy.
James Gray generated £1.79 million of revenue, £1.27 million ...
Renforth Resources CEO Nicole Brewster joined Steve Darling from Proactive to discuss new drilling results from the company’s Victoria nickel-cobalt polymetallic deposit near Malartic, Québec, along with a new research collaboration with Queen’s University focused on developing a potentially mor ...
Royal Road Minerals Ltd (TSX-V:RYR, OTC:RRDMF, FRA:RLU) CEO Dr Tim Coughlin spoke with Proactive's Stephen Gunnion about the latest exploration work at the Margaritas target in Colombia, where the company has identified significant silver-antimony veins as it continues its search for a deeper po ...
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire spoke with Proactive's Stephen Gunnion about the company's Sirtuin-6 (SIRT6) therapy and detailed results from its SLAB (Sarcopenia and Longevity in Aged Beagles) study, presented publicly for the first time at the Animal ...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada Proactive, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.
SUNTING
Terima kasih kerana membantu memastikan pangkalan data podcast dalam keadaan terkini.